Danaher Co. (NYSE:DHR) Shares Sold by Childress Capital Advisors LLC

Childress Capital Advisors LLC cut its holdings in Danaher Co. (NYSE:DHR) by 7.8% during the fourth quarter, HoldingsChannel reports. The firm owned 2,015 shares of the conglomerate’s stock after selling 171 shares during the period. Childress Capital Advisors LLC’s holdings in Danaher were worth $463,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in the business. Heck Capital Advisors LLC acquired a new position in shares of Danaher in the fourth quarter valued at approximately $27,000. Decker Retirement Planning Inc. acquired a new position in Danaher in the 4th quarter valued at $31,000. Teachers Insurance & Annuity Association of America purchased a new stake in shares of Danaher in the third quarter valued at about $39,000. MidAtlantic Capital Management Inc. acquired a new position in shares of Danaher during the third quarter worth about $40,000. Finally, FSA Wealth Management LLC acquired a new position in Danaher during the 3rd quarter worth approximately $50,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of DHR stock opened at $214.09 on Tuesday. The company has a market capitalization of $154.64 billion, a P/E ratio of 40.55, a price-to-earnings-growth ratio of 2.80 and a beta of 0.83. Danaher Co. has a 52 week low of $214.03 and a 52 week high of $281.70. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The company’s 50 day moving average price is $235.40 and its two-hundred day moving average price is $253.09.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period last year, the firm earned $2.09 EPS. On average, analysts expect that Danaher Co. will post 7.77 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Friday, December 27th were paid a $0.27 dividend. The ex-dividend date of this dividend was Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.50%. Danaher’s dividend payout ratio (DPR) is currently 20.45%.

Insiders Place Their Bets

In other news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 10.90% of the company’s stock.

Analyst Ratings Changes

Several research analysts have weighed in on DHR shares. KeyCorp upped their target price on shares of Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 23rd. Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 target price on the stock in a report on Thursday, October 31st. TD Cowen lifted their price target on Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. UBS Group reduced their price target on shares of Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a report on Wednesday, October 23rd. Finally, StockNews.com downgraded Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, December 14th. Seven investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $278.00.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.